NAGE
Niagen Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.56
+8.68%Forward multiples
Based on analyst estimates
- P/E forward
- 32.56x
- P/E 2026E
- 23.79x
- P/E 2027E
- 24.43x
- P/E 2028E
- 13.71x
- P/S forward
- 1.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.21x
- PEG TTM
- —
- Price / book
- 2.46x
- Price / sales
- 1.57x
- Price / cash flow
- 34.12x
Enterprise value
- Enterprise value
- $138.5M
- EV / sales
- 1.07x
- EV / EBITDA
- 7.56x
- EV / EBIT
- 16.08x
- Market cap
- $203.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026